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Abstract
Several forebrain and brainstem neurochemical circuitries interact with peripheral neural and humoral signals to collaboratively
maintain both the volume and osmolality of extracellular fluids. Although much progress has been made over the past decades
in the understanding of complex mechanisms underlying neuroendocrine control of hydromineral homeostasis, several issues
still remain to be clarified. The use of techniques such as molecular biology, neuronal tracing, electrophysiology,
immunohistochemistry, and microinfusions has significantly improved our ability to identify neuronal phenotypes and their
signals, including those related to neuron-glia interactions. Accordingly, neurons have been shown to produce and release a
large number of chemical mediators (neurotransmitters, neurohormones and neuromodulators) into the interstitial space, which
include not only classic neurotransmitters, such as acetylcholine, amines (noradrenaline, serotonin) and amino acids
(glutamate, GABA), but also gaseous (nitric oxide, carbon monoxide and hydrogen sulfide) and lipid-derived (endocanna-
binoids) mediators. This efferent response, initiated within the neuronal environment, recruits several peripheral effectors, such
as hormones (glucocorticoids, angiotensin II, estrogen), which in turn modulate central nervous system responsiveness to
systemic challenges. Therefore, in this review, we shall evaluate in an integrated manner the physiological control of body fluid
homeostasis from the molecular aspects to the systemic and integrated responses.
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Introduction
In mammals, both fluid volume and osmolality levels
are maintained by complex neuroendocrine, autonomic,
hemodynamic, renal, and behavioral mechanisms. The
harmonic operation of these systems is dependent on the
presence of the following factors: 1) sensors, located at
strategic positions within the central nervous system
(CNS), circulatory system, liver, and kidneys, which
detect changes either in the volume (mechanoreceptors:
volume or pressure-receptors) or osmolality (osmo/
sodium receptors) of the extracellular fluid (ECF); 2)
specific structures of the CNS responsible for the
reception, analysis and integration of information and
the consequent induction of appropriate responses, which
are dependent on the integrity of the circuitry comprising
the humoral and neural receptive areas, such as the
circumventricular organs (CVOs) of the lamina terminalis
[the organum vasculosum of the lamina terminalis
(OVLT), the subfornical organ (SFO)], the area postrema
(AP), and the nucleus of the solitary tract (NTS), as well
as areas implicated in the central integration of the
visceral and somatic sensory inputs, such as the lateral
parabrachial nucleus (LPBN), habenula, medial septal
area (MSA), extended amygdaloid complex, paraventri-
cular (PVN) and supraoptic nuclei (SON) of the hypotha-
lamus, locus coeruleus (LC) and dorsal raphe nuclei
(DRN), among others, and 3) the specificity of neuro-
transmitters, neuromodulators and neuropeptides
involved in the control of sodium balance, which is
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determined by the expression of specific receptors or
signaling pathways. Once activated, these systems
control responses that involve the following: a) the
induction of thirst, salt appetite, or both; b) changes in
sympathetic activity; c) activation of local and/or systemic
renin-angiotensin-aldosterone systems (RAAS); d) activa-
tion of the hypothalamic-pituitary-adrenal (HPA) axis; d)
the secretion of vasopressin (AVP) and oxytocin (OT)
from the neurohypophysis, and e) the production of
natriuretic peptides (ANP, BNP and CNP) by the heart,
endothelial cells and brain (1-3). Thus, the objective of
this review is to describe the mapping and signaling of
neural pathways involved in the regulation of hydromin-
eral homeostasis, with specific emphasis on their pheno-
typic characterization.
The anatomical basis of body fluid
homeostasis: central and peripheral aspects
Over the past decades, several studies have been
conducted to identify the mechanisms and specific brain
areas involved in the regulation of ECF volume and
osmolality and the intake and excretion of water and
electrolytes. Plasma osmolality normally ranges from 280
to 295 mOsm/kg in complex mammals and, when an
increase in this parameter is detected, a number of
homeostatic mechanisms, such as thirst, AVP release
and renal water reabsorption, are stimulated.
Regarding these osmoregulatory mechanisms,
Gilman (4) first demonstrated that cellular dehydration
induced by an increase in the effective osmotic pressure
or in body fluid tonicity (rather than in the absolute osmotic
pressure) stimulates thirst or water intake. Ten years
later, Verney (5) proposed the presence of osmoreceptors
in the diencephalon, which are stimulated by the selective
increase in body fluid tonicity and regulate AVP release.
Since then, considerable effort has been made to
precisely pinpoint their exact location. Andersson’s (6)
studies indicated that the rostral and medial hypothala-
mus (close to the midline) were the most effective sites to
induce thirst after brain hypertonic sodium chloride
injections. Studies of lesions in the anteroventral wall of
the third ventricle (AV3V region) in goats, rats and sheep
demonstrated that the ablation of this region [which is
composed of several distinct brain areas, including the
preoptic periventricular region, the ventral part of the
median preoptic nucleus (MnPO), the anterior hypotha-
lamic periventricular area, and the OVLT], altered water
intake and AVP secretion (7-9). Evidence obtained from
experiments in which sodium concentrations in the
cerebrospinal fluid (CSF) were monitored during systemic
infusion of hyperosmotic solutions has highlighted interest
in the CVOs of the lamina terminalis as key sites for the
location of osmoreceptors (10,11). These results sug-
gested that these regions would be directly influenced by
CSF tonicity (regulated by both central and peripheral
administration of hyperosmotic solutions) and are con-
sistent with the hypothesis that osmoreceptors are
located in brain regions lacking the blood-brain barrier.
Thus, these studies concluded that the CVOs, due to their
strategic localization, would fit the requirements of being
not only accessible and permeable to solutes such as
glucose, sodium chloride and urea, but also capable of
being influenced by ECF tonicity, thus arising as a
possible anatomic locus for osmoreceptors.
In this regard, McKinley’s group (12) has proposed that
osmoreceptors are located specifically in the OVLT and
SFO, two CVOs located at the midline of the AV3V region.
Consistent with evidence provided by these studies,
McKinley et al. demonstrated that lesions performed in
the OVLT (13,14) and SFO (15) reduced water intake and
AVP release in response to systemic hypertonicity.
Subsequent electrophysiological evidence showed that
some cells in both CVOs altered their electrical activity in
response to changes in the tonicity of their medium, being
intrinsically osmosensitive because these responses were
not altered by the blockade of their synaptic inputs (16,17).
In this context, the MnPO, which consists of the lamina
terminalis, the SFO and OVLT, is also important because it
receives afferent inputs from both CVOs (18), and its
specific ablation disrupts osmotically induced water intake
in rats (19).
Regarding the participation of the hypothalamus in
these responses, one of the first hypothetical neural
circuitries for the regulation of sodium balance was also
established from lesion experiments. The results sug-
gested that the hypothalamus represented the main
organizer, equilibrating stimulatory and inhibitory inputs
that emerged from extra-hypothalamic structures, mainly
from the limbic system. According to this model, the
hypothalamus is divided into two regions: the anterome-
dial hypothalamus (AMH), which stimulates salt replen-
ishment, and the anterolateral hypothalamus (ALH),
which inhibits systemic sodium gain and/or prevents its
loss-induced replacement. Projections from the basolat-
eral amygdaloid complex stimulate the AMH and inhibit
the ALH, whereas the corticomedial connections exert the
opposite effects. The septal area and olfactory bulb
constitute additional sources of predominantly stimulatory
inputs to the inhibitory areas of both the amygdala and
hypothalamus, reinforcing the inhibitory drive of salt intake
pathways activated by these areas.
Therefore, the basis provided by the above mentioned
pioneering studies establishing the first hypothetical
neural circuitry for the regulation of fluid homeostasis
has been substantially changed within the past few
decades due to advances in the methodological
approaches used (more restricted lesions, electrophysio-
logical recordings, and expression of immediate-early
gene products, among others). As previously mentioned,
the forebrain and brainstem receptive areas as well as the
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regions involved in the integration of visceral and somatic
sensory signals were also included in this circuitry.
Therefore, the SFO and OVLT contain cells that are
sensitive to alterations in plasma and CSF composition,
such as those related to humoral signals, sodium
concentrations, osmolality, and angiotensin II (ANGII)
levels. Such unique features make the SFO and OVLT
key brain regions to sense the status of body fluids and
electrolytes. Humoral signals are then transmitted from
the SFO and OVLT mainly via the MnPO to other
structures in the CNS, including the hypothalamus and
brainstem (3).
It has been previously demonstrated that high-
pressure mechanoreceptors, located not only in the
systemic circulation but also in renal vessels, integrate
ascending inputs that activate the brainstem and other
diencephalic structures following an increase in the
extracellular volume (2). Accumulating evidence indicates
that the NTS is an important component of a central
neural network related to the control of cardiovascular
function and body fluid homeostasis, processing viscerally
derived information, such as signals mediated by cardi-
opulmonary receptors. Noradrenergic cells of the LC are
included in the pathway that modulates homeostatic
responses induced by changes in the circulating volume.
These connections convey information regarding the
regulation of hormone secretion and the activity of the
sympathetic nervous system as well as initiate behavioral
adjustments with the objective of restoring body fluid
homeostasis (2).
Moreover, other studies have shown that some CNS
areas are also synaptically connected to the kidneys. Sly
et al. (20) demonstrated that the injection of a neuro-
trophic virus in the kidney induces the retrograde labeling
of neuronal clusters involved in homeostatic regulation. In
addition to the spinal cord, several forebrain regions,
including the OVLT, MnPO, SFO, the bed nucleus of the
stria terminalis, anteroventral periventricular nucleus,
medial and lateral preoptic areas, primary motor cortex,
and the visceral area of the insular cortex, were also
included in this circuitry. Moreover, renal innervation,
which is considered to be entirely of sympathetic origin,
participates in the homeostatic regulation of extracellular
volume and osmolality by controlling three important
aspects of renal function: blood flow, tubular reabsorption
of electrolytes and renin secretion. In the last decade, the
heart has also been shown to be an important mediator of
brain-kidney integrated responses related to fluid balance.
The microinjection of hypertonic saline into the AV3V
region of water-loaded rats induces natriuresis and
diuresis, both of which are effects attributable to the
production and release of natriuretic peptides, particularly
ANP, by cardiomyocytes into the systemic circulation (2).
It is well known that the central ANPergic system interacts
with neurohypophyseal hormones, particularly OT. This
hormone, in turn, may act directly on the kidneys to
promote natriuresis (an effect observed in rodents, but not
in other species) as well as on cardiomyocytes to
stimulate ANP production and release. Therefore, the
investigations conducted thus far point to the participation
of central and peripheral pathways in the control of water/
sodium retention (AVP and sympathetic nervous system)
and excretion (natriuretic peptides) (2).
Main neural pathways involved in the
regulation of ECF volume and osmolality
The integration of forebrain sodium/osmosensitive
areas and the hypothalamus via angiotensinergic,
cholinergic and adrenergic pathways
In the 1960’s, Grossman (21) published the first
studies that demonstrated neurotransmitter activity-con-
trolled synaptic function in hypothalamic structures that
regulate body fluid homeostasis. Moreover, these studies
demonstrated that stimulation of the hypothalamus with
adrenergic and cholinergic agonists induced an increase
in food and water intake, respectively. Several other
studies have shown that in euhydrated animals, choliner-
gic and angiotensinergic stimulation of the AV3V region
results in a rapid increase in water intake, followed by
natriuresis (22,23), suggesting that cholinergic projections
to the hypothalamus may represent an important pathway
regulating osmotic imbalances. Subsequent studies have
shown that the administration of cholinergic and alpha-
adrenergic agonists or antagonists into the septal area,
AV3V or third ventricle modulates the natriuretic, anti-
diuretic and kaliuretic responses induced by carbachol.
Taken together, the main findings in this area suggest that
sodium/osmosensitive neurons located in the CNS modify
renal sodium excretion via a stimulatory pathway involving
cholinergic and alpha-adrenergic receptors and inhibit
sodium excretion via a tonically active beta-adrenergic-
mediated pathway.
The fluid balance-integrated responses of the
hindbrain mediated by the serotonergic system
Serotonin (5-HT) has been implicated in the inhibitory
control of salt and water intake (24), particularly seroto-
nergic neurons with their soma in the DRN and 5-HT
terminals within the LPBN. Bilateral injections of the
nonselective 5-hydroxytryptamine (5-HT1/2) receptor
antagonist, methysergide, into the LPBN significantly
reversed the inhibitory effects of the intracerebroventri-
cular (icv) injection of carbachol on 0.3 M NaCl intake
(25). These results suggest that the LPBN integrates a
satiety pathway that downregulates sodium-seeking
behaviors, the mechanism of which may involve bidirec-
tional connections with prosencephalic structures, such
as the lamina terminalis, hypothalamus and brainstem.
Studies evaluating c-Fos immunoreactivity have
demonstrated that the activity of serotonergic cells within
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the DRN is affected by sodium status (26). Accordingly, c-
Fos expression was decreased in sodium-depleted
animals and increased when the animals were either in
balance or in the process of restoring sodium home-
ostasis by ingesting 0.3 M NaCl solution. 5-HT is also
released by axonal terminals and somatodendritic var-
icosities within the DRN, where it acts on 5-HT1A
autoreceptors to negatively modulate the serotonergic
system, thereby decreasing the spontaneous firing rate of
serotonergic neurons (27). These results are consistent
with the concept that there is a tonic inhibition of sodium
appetite exerted on the LPBN by serotonergic cells
originating in the DRN. Such an inhibitory influence is
likely to be reduced in a state of fluid deficiency and
increased when the animals ingest water and NaCl to
restore hydromineral balance. Such a mechanism would
be important in preventing excessive NaCl consumption
and would reduce the possibility of excess extracellular
volume expansion, thus allowing a faster recovery of
plasma osmolality, sodium concentration and extracellular
volume during the satiety phase of sodium appetite.
These changes are detected and integrated by neurons of
the lamina terminalis, and then projected to the DRN via a
monosynaptic connection (28).
Moreover, the serotonergic system may be subject to
desensitization because an acute intra-DRN administra-
tion of 8-OH-DPAT, a 5-HT1A agonist, evoked an
additional and significant increase in sodium intake in
sodium-depleted rats, whereas repeated 8-OH-DPAT
intraperitoneal or intra-DRN injections over 6 days
resulted in a long-lasting reduction in cumulative sodium
intake (29). According to these studies, this regulatory
mechanism would be potentially associated with a
reduction in 5-HT1A receptor density or with changes in
G-protein receptor coupling.
More recently, it has been demonstrated that seroto-
nergic terminals of the LPBN originating from DRN
serotonergic somas also participate in the regulation of
renal and hormonal responses induced by an isotonic
increase in the ECF (30). Animals with electrolytic lesions
of the DRN or with serotonin depletion induced by the
central administration of p-chlorophenylalanine display
attenuated ANP release, both under resting conditions
and after extracellular volume expansion (31). Taken
together, these behavioral and neuroendocrine observa-
tions suggest that the serotonergic system acts via
differential projecting pathways and receptor mechanisms
to induce sodium satiety, which may include 1) a
barosensitive mechanism; 2) a reduced aversion to salt
during hyponatremia, as deduced from evidence suggest-
ing the presence of specific sodium channels in the SFO,
and 3) elevated plasma ANGII concentrations, which may
sensitize the CVOs (1,3,32).
The midbrain and hindbrain GABAergic systems
GABA, the major inhibitory neurotransmitter in the
mammalian CNS, mediates the inhibitory actions of
interneurons in the brain, as well as the presynaptic
inhibition in the spinal cord. The main ionotropic subtype
of GABA receptors in the brain is GABAA, which consists
of a ligand-operated chloride ion channel. This channel is
opened in response to GABA release by presynaptic
neurons, mediating phasic inhibition, or following the
activation of extrasynaptic receptors, mediating tonic
inhibition of the postsynaptic cell (33).
It has been shown that inhibitory mechanisms in the
LPBN and central GABAergic mechanisms are involved in
the regulation of behavioral responses particularly related
to water and sodium intake. The activation of GABAA
receptors by muscimol (a GABAA agonist) injected into
the LPBN induces the ingestion of water and 0.3 M NaCl
solution in both euhydrated and hyperosmotic cell-
dehydrated rats, with the effect on sodium intake being
reversed by the administration of bicuculline, a GABAA
antagonist (34).
Furthermore, GABA plays a major role in the control of
neurohypophyseal output because both GABA and
muscimol decrease hypertonicity-induced AVP release
(35). GABA also reduces the firing rate of AVP-secreting
neurons when applied microionophoretically into the SON
of rats (36). Thus, many questions remain unanswered
regarding how an increase in volume affects neurohypo-
physeal hormone secretion and which neural pathways
are responsible for conveying the signal from cardiac and
arterial baroreceptors to the hypothalamus. GABAergic
nerve terminals have been observed in neurosecretory
nerve endings in the neurohypophysis (37), suggesting an
important role for the inhibitory neurotransmitter GABA in
regulating the activity of OT and AVP neurons. It is known
that extracellular volume expansion (EVE) activates CNS
regions associated with the inhibition of AVP release and
sympathetic nerve activity and stimulates OT secretion
(2). Consistent with these findings, it has been proposed
that the perinuclear zone of the SON, a GABAergic region
surrounding this hypothalamic nucleus, constitutes the
major source of inhibition in AVP neurons following an
acute increase in blood pressure, thus decreasing the
activity of AVP-secreting cells of the SON in response to
stretching of the caval-atrial junction (38).
Other sources of GABAergic inputs to the hypotha-
lamic neurohypophyseal system have also been
described, including the amygdaloid complex. The central
amygdaloid nucleus (CeA) and the bed nucleus of the
stria terminalis (BNST), which is considered to be a
component of the ‘‘extended amygdala’’, establish impor-
tant connections with the hypothalamus and other brain
areas controlling visceral and sensory information.
Furthermore, increases in urine output, renal sodium
excretion, and plasma OT and ANP concentrations
induced by isotonic and hypertonic EVE are attenuated
in rats pretreated with muscimol into the CeA. Bicuculline,
an antagonist of GABAA receptors, injected into the CeA,
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also reduced the effects of hypertonic EVE on urinary
volume and ANP secretion (39). Thus, taken together,
these data suggest that the CeA GABAergic mechanisms
are involved in the control of ANP and OT secretion, as
well as in the control of sodium and water excretion in
response to isotonic and hypertonic increases in the ECF.
Furthermore, icv injection of GABA agonists
decreases arterial blood pressure, heart rate and sympa-
thetic nerve activity, while icv injections of GABA
antagonists such as bicuculline markedly increase arterial
blood pressure and heart rate due to an increase in
sympathetic nerve activity (40). Accumulating evidence
supports a blunted GABAergic inhibition within the PVN
as a critical mechanism contributing to sympathoexcita-
tion in cardiovascular-related disorders, including hyper-
tension (41). Inhibition of neuronal excitability in
hypothalamic oxytocinergic and vasopressinergic neurons
by nitric oxide (NO) involves pre- and postsynaptic
potentiation of GABAergic synaptic activity in the SON
(42). Numerous studies have shown that the neuronal
activity in the PVN, as well as the sympathetic outflow
from the PVN, is basally restrained by a GABAergic
inhibitory tone (43). Taken together, these results suggest
that GABA activity or its interaction with other neuromo-
dulators is dependent on a particular physiological
condition and may result in either a positive or negative
feedback compensatory mechanism to coordinate com-
plex neuroendocrine, behavioral and autonomic output
patterns.
The local modulation of synaptic function
The understanding of the complex central circuitries
involved in the control of hydromineral balance was
dramatically increased after the discovery that the CNS
produces several peptides/hormones that were primarily
identified in the periphery. Accordingly, neurons not only
express several receptor systems but also synthesize
hormones that are released into the interstitial space
where they modulate synaptic function in an autocrine or
paracrine manner. This mechanism is supported by
evidence of the local expression of specific enzymatic
pathways and precursors. In the following sections, this
review will address the contribution of local modulators of
synaptic function to the control of water and sodium
balance, as well as introduce glial cells and gliotransmit-
ters as active elements within this context.
Neuropeptides. ANGII, when injected into specific
areas of the CNS, exhibits dipsogenic and natriorexigenic
effects. It has been well demonstrated that the AV3V
region robustly expresses not only type 1 (AT1) ANGII
receptors, which are responsible for most of the ANGII-
mediated behavioral effects, but also angiotensinergic
terminals. This peptide is produced in the CNS indepen-
dently of the circulating RAAS, which raises the possibility
that endogenous brain-derived ANGII may be involved in
the physiological regulation of water and salt intake;
although there have been no conclusive demonstrations.
Conversely, the widespread distribution of ANGII recep-
tors throughout the CNS suggests that this locally
produced peptide may have a more complex function
not related to the control of water and salt appetite (1,3).
The presence of ANP-secreting neurons and ANP
receptors in CNS structures related to the homeostatic
control of hydromineral homeostasis and cardiovascular
function has also been demonstrated (44). It has been
reported that ANP or CNP injected into the AV3V region
decreases plasma ANP concentration in volume-
expanded rats, with no change in mean arterial pressure
or heart rate (45). Thus, local increases in ANP within the
CNS elicited by EVE might constitute a feedback loop that
inhibits ANP neuronal activity (2).
Autocrine mechanisms have also been shown to
regulate the activity of the magnocellular neurosecretory
system. Consequently, OT is released from somatoden-
drites of SON magnocellular neurons and acts on
presynaptic autoreceptors to facilitate the release of
endocannabinoids (ECBs) and GABA, which in turn inhibit
neuronal activity (46). Furthermore, the hypoosmolality-
induced somatodendritic release of AVP by SON neurons
and the local activation of type 2 AVP (V2) receptors have
been recently implicated in the mediation of cell volume
regulation in vitro (47).
Gaseous neuromodulators. Soluble gases have a
short half-life, which limits their actions on neighboring
cells that express or are in close proximity to the
enzymatic machinery responsible for their synthesis.
Once produced, these highly membrane-permeable
molecules are rapidly converted into ineffective products
by specific chemical reactions. The neuronal isoform of
NO synthase enzyme (nNOS), which is responsible for
the production of NO within the CNS, is expressed in
several cell clusters, including the lamina terminalis,
magnocellular neurosecretory cells of the SON and PVN
nuclei and the posterior pituitary (48). Furthermore, NO
modulates the activity of the magnocellular neurosecre-
tory system. Rats that are centrally or peripherally injected
with L-NAME, a non-selective NOS inhibitor, show
increased plasma AVP and OT concentrations (49).
Interestingly, upregulation of NOS mRNA and NOS
activity is induced in rats subjected to chronic salt loading
(50), suggesting that mechanisms responsible for the
prevention of hormonal depletion may be activated after
prolonged exposure to these life-limiting conditions.
Several studies using extracellular and intracellular
recordings have demonstrated that the NO precursor L-
arginine decreases, whereas L-NAME increases, the
firing frequency of magnocellular neurosecretory cells,
suggesting a tonic inhibitory effect on neuronal activity
(51). Accordingly, NO increases the amplitude and
frequency of GABA miniature inhibitory postsynaptic
currents in SON magnocellular neurons, suggesting
that NO inhibition of SON neuronal excitability involves
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pre- and postsynaptic potentiation of GABAergic synaptic
activity (42).
Peripherally, the secretion of ANP by the heart is also
modulated by local NO production. The main findings
reported so far have supported an inhibitory role for NO in
ANP release, a mechanism that seems to be disrupted
and to contribute to the development of heart failure (52).
In the kidneys, NOS is present in vascular and tubular
elements, and sustained changes in NO synthesis have
been implicated in some pathological conditions, such as
glomerulonephritis and chronic kidney disease (53).
Carbon monoxide (CO) is another gaseous modulator
with potential effects on body fluid homeostasis. It is one
of the most toxic molecules in nature, and its main
biological effect consists of activating cyclic guanosine
monophosphate production, with reported effects on
synaptic plasticity and neuromodulation (54). The dis-
covery of high levels of heme oxygenase (HO) in the
brain, however, strongly suggested a role for CO-
mediated signaling in central physiological functions. In
the hypothalamus, a recent study showed that immuno-
reactivity for type 1 HO (HO-1) in both vasopressinergic
and oxytocinergic neurons is increased by water depriva-
tion (55). Accordingly, inhibition of HO was shown to
decrease the hyperosmolality-induced release of OT and
ANP by the medial basal hypothalamus in vitro (56).
Similarly, inhibition of this enzyme also induced a strong
hyperpolarization and a decrease in the firing rate of
magnocellular neurosecretory cells in water-deprived
animals (55). In addition to acting individually, CO has
also been shown to interact with the nitrergic system to
control hydromineral homeostasis. Moreover, use of an
HO inhibitor increases the production of L-citrulline, a co-
product of NO synthesis, by the medial basal hypothala-
mus in vitro in response to hyperosmolality (56). Thus, CO
appears to play a predominantly facilitatory role in AVP
and OT release, although most studies suggest that NO
has an opposite effect, inhibiting AVP and OT release. On
the basis of the evidence that the final products of both
NOergic and COergic systems can reciprocally affect
enzymatic activity, it can be suggested that these two
systems integrate to form a feedback loop implicated in
the local control of hypothalamic neurosecretory system
output.
The last gaseous neuromodulator to be described was
H2S, which is endogenously produced in relatively large
amounts by the CNS. The enzymes cystathionine-b-
synthase and cystathionine-c-lyase are responsible for
H2S synthesis from L-cysteine. Both the expression and
activity of these isoforms are known to be modulated by
other signaling molecules such as Ca2+, as well by
circulating hormones such as insulin, glucagon and
glucocorticoids (57). Although experimental evidence
linking H2S to hydromineral homeostatic control has not
yet been reported, a potential role for this nonconventional
neurotransmitter in the regulation of neuroendocrine
output could be speculated because H2S has been shown
to interact with NO and CO (57).
Endocannabinoids. In the past few years, endoge-
nously produced cannabinoids have emerged as impor-
tant signaling molecules mediating several physiological
processes, particularly the control of energy homeostasis.
The main ECBs that have been characterized thus far
include anandamide and 2-arachidonoylglycerol, which
are produced on demand by membrane phospholipids. A
receptor for cannabis-like substances (CB1R) was first
identified in 1988. The type 2 cannabinoid receptor
(CB2R) was characterized a few years later and exhibits
a very distinct expression profile. The physiological
actions of the ECB system are produced mostly by the
interaction of endogenous ligands with CB1R and/or
CB2R. However, the involvement of orphan receptors,
such as GPR55, in the mediation of some responses still
remains to be examined.
CB1R is a G-protein coupled receptor (GPCR) whose
activation affects neurotransmission and signal transduc-
tion. Most of its previously described effects are related to
1) inhibition of the adenylyl cyclase-mediated pathway, 2)
activation of potassium channels, and 3) inhibition of
voltage-gated calcium channels (58). Over the past few
years, the identification of potential antagonists for the
ECB system has been of great interest since CB1R was
identified as an important target in the control of metabolic
diseases, particularly those related to increased abdom-
inal adiposity. However, the assumption that GPCRs,
including CB1R, can assume multiple conformations and
affinity states has dramatically increased the possibilities
by which potential drugs can affect CB1R-mediated
signaling. Thus, several studies have suggested that the
ECB system may be active under basal conditions. The
constant production and release of ECBs, the presence of
constitutively activated CB1R, and the presence or
absence of relatively low concentrations of the endoge-
nous ligands would contribute to this basal activity (59).
An emerging role for ECBs consists of their mediation
of glucocorticoid-related effects, particularly in the CNS.
Activation of the HPA axis, with the consequent release of
glucocorticoids, is known to exert an inhibitory effect on
the activation of most neuroendocrine functions, including
the synthesis/secretion of neurohypophyseal peptides,
particularly OT (60). Nongenomic signaling pathways
activated by the binding of glucocorticoids to conserved
cell membrane sites have been characterized, and this
mechanism has been implicated in the rapid changes
observed in neurotransmission following an increase in
circulating glucocorticoid levels.
The local production and release of ECBs within the
PVN and SON in the presence of glucocorticoids results
in decreased glutamatergic and increased GABAergic
inputs to both parvocellular and magnocellular neurons
in vitro (61). In addition to directly stimulating GABA
neurotransmission, glucocorticoids also stimulate NO
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release, which potentiates the negative drive to these cell
groups. CB1R is the main isoform involved in these
responses because rimonabant, a CB1R antagonist,
potentiates the secretion of AVP and OT induced by a
hypertonic EVE, as well as reverses the inhibitory effects
of dexamethasone on hormonal release under the same
experimental conditions (62). Thus, together with gaseous
neuromodulators, locally produced ECB are important
signaling molecules that control hypothalamic function
in situ.
Glial cells and gliotransmitters. It has been proposed
that the SON exhibits an intrinsic osmosensitivity, which is
provided by changes in mechanosensitive cationic chan-
nels. These channels depolarize and hyperpolarize
magnocellular neurons that are exposed to hyperosmotic
or hypoosmotic conditions (63). Recent studies have
identified an additional osmoregulatory mechanism within
the SON involving astroglia, through which astrocytes
may regulate magnocellular excitability via gliotransmitter
release and neurotransmitter clearance and act as
osmosensory elements (31,64-67). Several studies have
demonstrated that taurine, an organic osmolyte, is
present in glial processes surrounding magnocellular
neurons. Moreover, several reports have also shown that
certain stimuli, such as hypotonicity, can induce an
increase in taurine release by astrocytes. This effect, in
turn, was shown to inhibit Ca2+ influx and contribute to a
decrease in AVP and OT release (64). Furthermore,
recent studies have demonstrated that astrocytes of the
SON are activated in response to acute exposure to
hypertonic saline, promoting glutamate release through
connexin-43 functional hemi-channels, which are the
predominant gap junction proteins expressed in astro-
cytes, and subsequently activating magnocellular neurons
(65,67). Furthermore, several studies have reported that
dehydration decreases the expression of type 1 glutamate
transporters in SON astrocytes (68), suggesting a
diminished astrocytic glutamate uptake with a consequent
increase in glutamate availability in the extracellular
space, which may result in the tonic activation of
presynaptic glutamate receptors on neuronal terminals.
Because dehydration induces morphological changes
within the hypothalamus, this process may result in the
reduction of astrocyte-mediated exposure of magnocel-
lular neurons (69). Previous studies conducted by
Boudaba et al. (68) argue that this dehydration-induced
increase in extracellular glutamate accumulation could
also be modulated by the retraction of astroglial
processes around SON neurons, resulting in direct and
extensive juxtapositions of magnocellular neuronal sur-
faces.
Moreover, several studies have hypothesized that
Nax, an atypical sodium channel, may constitute an
important sodium sensor within the CNS (32,70,71).
Watanabe et al. (70) demonstrated that salt-aversive
behaviors induced by dehydration were abolished in Nax
-/-
transgenic mice. Moreover, infusion of either mannitol or
isotonic saline into the cerebral ventricle induced similar
behavioral effects on water and sodium intake in Nax
+/+
and Nax
-/- mice, suggesting that Nax is particularly
sensitive to extracellular sodium concentrations.
Furthermore, these studies also showed that the Nax
channel is expressed in the perineuronal processes of
astrocytes and ependymal cells in sensory CVOs. The
mechanism by which astrocytes are activated by
increased ECF sodium concentrations was recently
demonstrated by Shimizu and his group (71), who
revealed a dehydration-induced opening of Nax channels,
which resulted in 1) increased intracellular sodium
concentrations, 2) increased Na+/K+-ATPase activity
and ATP expenditure, and 3) stimulation of anaerobic
glucose metabolism and lactate release by astrocytes,
supplying SON neurons with this energy source.
Furthermore, the same group has demonstrated that the
dehydration-induced lactate release by astrocytes acti-
vates SFO GABAergic neurons via the production of ATP,
with this mechanism presumably being implicated in the
control of salt intake.
Recent functional experiments performed by our
group have also demonstrated that the central adminis-
tration of ANGII stimulates AVP and OT release (49). It
has been previously reported that both AT1 and AT2 are
widely distributed in the hypothalamus, as they are
expressed in both neuronal cell types and in astrocytes
(72). This study also demonstrated that AT2 receptors are
expressed in astrocytes juxtaposed to magnocellular
neurons in the PVN. Although these studies have
suggested that centrally produced ANGII activity on
hypothalamic astrocytes may play an important role in
hydromineral balance, the mechanisms underlying these
effects still remain unclear.
Peripheral hormones alter the
responsiveness of the CNS to body fluid
disturbances: focus on estrogen actions
The first studies that proposed that gonadal hormones
are involved in the control of hydromineral balance
stemmed from data showing that water intake and sodium
appetite varied along the estrous cycle. Accordingly,
studies by Antunes-Rodrigues et al. (73) reported a
spontaneous decrease in sodium intake during estrus,
which is the stage when the female reproductive cycle
undergoes high plasma estrogen concentrations, and an
increase in sodium intake during diestrus, when low
plasma levels of estrogen are detected. Treatment with
estradiol attenuates water intake in OVX animals receiv-
ing hyperoncotic colloid (74) or isoproterenol and hyper-
tonic saline (75), or animals subjected to water deprivation
(76). Other groups have reported that estrogen therapy
decreases not only water intake but also abolishes salt
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ingestion induced by central ANGII administration in OVX
rats (77).
More recently, the participation of the RAAS in the
mediation of the behavioral responses induced by
estradiol has been demonstrated. Estradiol was shown
to inhibit ANGII AT1 receptors and angiotensin-converting
enzyme (ACE) expression in the SFO (78). Furthermore,
it was also demonstrated by our group that the central
AT1 blockade in OVX rats inhibits 1) the dipsogenic
response induced by water deprivation, osmotic stimula-
tion, chronic sodium depletion and furosemide + captopril
(furo + cap) experimental models and 2) the natriorexi-
genic response induced by sodium depletion (77,79).
These studies also demonstrated that estrogen signifi-
cantly attenuates the losartan inhibition of thirst and
sodium appetite driven by sodium depletion and furo +
cap experimental models. Consistent with recent evi-
dence from the literature suggesting a potentially protec-
tive effect of estradiol on the cardiovascular system, these
observations further support a role for this hormone in the
behavioral control of water and salt intake because of the
clearly demonstrated influence of estrogenic status on the
AT1-mediated behavioral responses.
In addition to the modulation of several mechanisms
involved in the induction of drinking behavior, estrogen
also modulates inhibitory serotonergic mechanisms
controlling salt intake. Several studies have demon-
strated that estrogen modulates the basal firing rate of
serotonergic neurons (80) and enhances serotonin
transporter mRNA expression in the DRN of OVX
animals (81). Furthermore, when estrogen is chronically
administered to OVX rats, an increase in the mRNA
expression for tryptophan hydroxylase-2 is observed in
the DRN (82). More recently, it was also demonstrated
that the estrogen-dependent inhibition of sodium appetite
in both normal cycling rats and OVX animals with
estradiol replacement may involve an interaction
between excitatory neurons of the OVLT and the
inhibitory serotonergic drive of the DRN, which are key
pathways that underlie the responses to hyponatremia
and hypovolemia (83).
Further effects of estrogens on fluid balance involve
the control of neurohypophyseal hormones and ANP.
Changes in plasma AVP during the reproductive cycle
have been previously reported (84). Furthermore, several
studies have proposed a stimulatory role for estradiol on
OT and ANP secretion (85,86). More recently, the
contribution of estradiol to AVP, OT and ANP secretion
as well as to vasopressinergic and oxytocinergic neuronal
activation has been demonstrated (87,88). Estradiol has
been shown to positively modulate AVP and OT secretion
in response to osmotic stimulation induced by hypertonic
extracellular volume expansion (87) and hypovolemic
shock (88), without altering ANP secretion. These same
studies also showed that the activity of both oxytocinergic
and vasopressinergic neurons in the SON and PVN may
be modulated by estradiol.
Taken together, these findings are strongly supported
by the evidence that estradiol receptor beta (ER-b) is
expressed in the SON and PVN, where it co-localizes with
AVP and OT (89), and the ER alpha (ER-a) is expressed
in afferent osmosensitive neurons located in the SFO and
OVLT that project to the SON and PVN (90). Thus,
modulation exerted by estradiol on vasopressinergic and
oxytocinergic activity could be produced by a direct effect
because PVN and SON neurons express ER-b, and/or by
an indirect mechanism of action presumably arising from
the lamina terminalis. In this context, the hyperosmolality-
induced activation of first-order ER-a-expressing neurons
of the CVOs could produce a subsequent activation of
vasopressinergic and oxytocinergic neurons in the SON
and PVN. This latter hypothesis is supported by a recent
study showing that AVP immunoreactivity in the SON and
PVN is significantly elevated in response to treatment with
an ER-a agonist, but not with an ER-b agonist, suggesting
that estradiol may regulate vasopressinergic neuronal
activity by acting on afferent neurons expressing ER-a.
Furthermore, the hypovolemia-induced activation of cen-
tral areas controlling plasma volume and arterial pressure,
such as the SFO, may also be modulated by estradiol.
Taken together, these data indicate that estradiol
participates in the control of fluid balance by the following
mechanisms: 1) increasing the responsiveness of vaso-
pressinergic and oxytocinergic neurons in the PVN and
SON as well as the secretion of the AVP and OT
neuropeptides; 2) increasing the release of natriuretic
factors (ANP and OT) in response to osmotic stimulation
or other systemic challenges, 3) decreasing brain ANGII
responsiveness via the modulation of AT1-mediated
signaling, and 4) increasing the DRN serotonergic activity,
which consequently inhibits salt appetite.
Conclusions and Perspectives
The identification and the characterization of the
phenotypical pathways activated in the CNS in response
to peripherally produced signals have significantly
improved our understanding of the redundant mechan-
isms controlling body fluid homeostasis. These pathways
are mediated not only by classic neurotransmitters such
as acetylcholine, amines (noradrenaline, serotonin) and
amino acids (glutamate, GABA), but also by gaseous
(NO, CO and H2S) and lipid-derived (ECBs) mediators.
The efferent responses initiated within the neuronal
environment and modulated by glial cells recruit several
peripheral effectors (such as glucocorticoids, ANGII,
estrogen), which in turn modulate central responsiveness
to systemic challenges. Since most of these hormones
produce a broad range of effects in the CNS, the future
directions in this field are now being aimed at 1) the
identification of specific signaling pathways that may
characterize site-specific actions, as well as 2) the in situ
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manipulation of these cascades in different brain areas.
This latter objective may be accomplished, among other
methodological strategies, by the use of local modulators
of gene activity, such as viral vectors, which induce in vivo
gene transfer, down- or upregulating endogenous gene
function. Furthermore, the evidence that these brain
networks can be affected by plasticity has also focused
attention on the importance of fetal programming and
aging-related changes for the integrity of homeostatic
responses regarding hydromineral balance.
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